All News Politics PSA NewsWire

Psychedelic Culture The Psychedelic Bookshelf The Psychedelic Silver Screen

Policy Tracker Market Directory

Commentary Events

About PSA Partnerships Authors Tags Archive

Home
Markets
Nasdaq Cmps

Market Directory / Compass Pathways

Compass Pathways

CMPS

NASDAQ

Biotech

Open on TradingView

Clinical-stage biotech developing COMP360 synthetic psilocybin for treatment-resistant depression.

Independent reporting, commentary, and archives at the intersection of psychedelic science, policy, and culture across the United States.

Newsroom

All News
Politics
Psychedelic Science
Psychedelic Culture
PSA NewsWire
Commentary

Explore

The Psychedelic Bookshelf
Archive
Tags

Organization

About PSA
Partnerships
Authors
Email Preferences

RSS Feeds

Full Archive
News
Politics
Psychedelic Science
Psychedelic Culture
The Psychedelic Bookshelf
Commentary
Events

© 2026 Psychedelic State(s) of America. All rights reserved.

Psychedelic News, Commentary, Analysis, and Education: For the People, By the People.